What is the official website of Fresenius Kabi ?

The official website of Fresenius Kabi is http://www.fresenius-kabi.com.

What is Fresenius Kabi's cybersecurity risk score?

Fresenius Kabi has an AI-generated cybersecurity risk score of 790 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Fresenius Kabi experienced?

According to Rankiteo, Fresenius Kabi currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Fresenius Kabi been affected by any supply chain cyber incidents ?

According to Rankiteo, Fresenius Kabi has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Fresenius Kabi have SOC 2 Type 1 certification ?

According to Rankiteo, Fresenius Kabi is not certified under SOC 2 Type 1.

Does Fresenius Kabi have SOC 2 Type 2 certification ?

According to Rankiteo, Fresenius Kabi does not hold a SOC 2 Type 2 certification.

Does Fresenius Kabi comply with GDPR ?

According to Rankiteo, Fresenius Kabi is not listed as GDPR compliant.

Does Fresenius Kabi have PCI DSS certification ?

According to Rankiteo, Fresenius Kabi does not currently maintain PCI DSS compliance.

Does Fresenius Kabi comply with HIPAA ?

According to Rankiteo, Fresenius Kabi is not compliant with HIPAA regulations.

Does Fresenius Kabi have ISO 27001 certification ?

According to Rankiteo,Fresenius Kabi is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Fresenius Kabi operate in ?

Fresenius Kabi operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Fresenius Kabi have ?

Fresenius Kabi employs approximately 23,880 people worldwide.

Does Fresenius Kabi own any subsidiaries ?

Fresenius Kabi presently has no subsidiaries across any sectors.

How many LinkedIn followers does Fresenius Kabi have ?

Fresenius Kabi's official LinkedIn profile has approximately 464,663 followers.

What is the NAICS classification code for Fresenius Kabi ?

Fresenius Kabi is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Fresenius Kabi have a Crunchbase profile ?

No, Fresenius Kabi does not have a profile on Crunchbase.

Does Fresenius Kabi have a LinkedIn profile ?

Yes, Fresenius Kabi maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/freseniuskabi.

How many cybersecurity incidents has Fresenius Kabi experienced ?

As of September 6, 2026, Rankiteo reports that Fresenius Kabi has not experienced any cybersecurity incidents.

How many peer or competitor companies does Fresenius Kabi have ?

Fresenius Kabi has an estimated 5,755 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Fresenius Kabi

Boost Score +25 with badge (5 left)

790

/1000

Fair

815

/1000

Good

Fresenius Kabi Vendor Cyber Rating & Cyber Score

fresenius-kabi.com

Add Your Compliance Badge

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices,

Fresenius Kabi A.I CyberSecurity Scoring

Scoring History

Fresenius Kabi

Fresenius Kabi CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Fresenius Kabi Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Fresenius Kabi

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fresenius Kabi in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Fresenius Kabi in 2026.

Incident Types Fresenius Kabi vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fresenius Kabi in 2026.

Incident History - Fresenius Kabi (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Fresenius Kabi Subsidiaries

Parent Company

Fresenius Kabi

Pharmaceutical Manufacturing

Website: http://www.fresenius-kabi.com

Company Size: 10,000+ employees

No subsidiary data available for this company.

Loading…

Fresenius Kabi Similar Companies

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Parexel

parexel.com

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

Loading…

NEWS

Fresenius Kabi CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

February 27, 2026 08:09 AM

Infusion Pump Market: Advancing Precision Drug Delivery in Modern Healthcare

The Infusion Pump Market represents a critical segment within modern healthcare technology, enabling controlled and accurate delivery of...

Read Article

August 08, 2025 11:34 AM

CRM Transformation: A strategic choice for leaders in Life Sciences

In the dynamic, highly regulated pharmaceutical and healthcare industry, effective customer relationship management (CRM) platforms and commercial...

Read Article

April 29, 2024 07:00 AM

Guarding the flow: Enhancing cybersecurity measures for infusion pump systems

Strengthening security measures in widely used hospital devices helps protect patient safety and the integrity of the healthcare system.

Read Article

July 24, 2023 07:00 AM

With updated FDA nod, BD aims to revive beleaguered Alaris infusion pumps

BD CEO Tom Polen noted that the newly FDA-cleared Alaris infusion pump system “addresses all open recalls,” spanning recent hardware, software and...

Read Article

September 09, 2022 07:00 AM

Baxter infusion pumps found to be at risk of remote hacking

Baxter's infusion pumps are in the crosshairs once again after a cybersecurity software developer discovered multiple vulnerabilities in the...

Read Article

December 22, 2021 08:00 AM

FDA, CISA Warn of Fresenius Kabi Infusion Pump Flaws

US government authorities have issued an advisory warning about remotely exploitable security vulnerabilities in certain Fresenius Kabi infusion pump systems.

Read Article

December 22, 2020 08:00 AM

Smart labels could smooth stressed medical supply chains

Mistakes, delays and shortages with medication are behind many preventable deaths. Smart new technology is changing that and saving everyone...

Read Article

May 07, 2020 07:00 AM

Ransomware Operators Hit Major Healthcare Supplier in Europe as COVID-19 Continues to Take Lives

Ransomware attackers have breached Europe”s largest private hospital operator, affecting not just its European branches, but every part of...

Read Article

May 06, 2020 07:00 AM

Europe’s Largest Private Hospital Operator Fresenius Hit by Ransomware

Fresenius, Europe's largest private hospital operator and a major provider of dialysis products and services that are in such high demand thanks to the COVID-...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-86150

SUMMARY

A security vulnerability has been detected in Tenda CP3 27.5.57.101. Impacted is an unknown function of the file custom-x/softap/hostapd. Such manipulation of the argument wpa_passphrase leads to hard-coded credentials. The attack can be launched remotely. The exploit has been disclosed publicly and may be used.

Published

Date2026-09-05

Updated

Date2026-09-05

RISK INFORMATION (Score: 4.1)

cvss2

Base Score: 3.3

Complexity: LOW

AV:N/AC:L/Au:M/C:P/I:N/A:N

cvss3

Base Score: 4.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:L/I:N/A:N

cvss4

Base Score: 2.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:N/VA:N/SC:L/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.3

REFERENCES

CVE-2026-86149

SUMMARY

A weakness has been identified in Tenda CP3 27.5.57.101. This issue affects some unknown processing of the file Net/NetCheckPing.cpp. This manipulation of the argument interface_name/host causes os command injection. The attack can be initiated remotely.

Published

Date2026-09-05

Updated

Date2026-09-05

RISK INFORMATION (Score: 9.1)

cvss2

Base Score: 8.3

Complexity: LOW

AV:N/AC:L/Au:M/C:C/I:C/A:C

cvss3

Base Score: 9.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 9.4

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

2.3

REFERENCES

CVE-2026-86148

SUMMARY

A security flaw has been discovered in Tenda CP3 27.5.57.101. This vulnerability affects the function SystemAsh of the file Apis/system.c of the component Kylin. The manipulation of the argument AlarmVoiceURL results in os command injection. It is possible to launch the attack remotely.

Published

Date2026-09-05

Updated

Date2026-09-05

RISK INFORMATION (Score: 9.1)

cvss2

Base Score: 8.3

Complexity: LOW

AV:N/AC:L/Au:M/C:C/I:C/A:C

cvss3

Base Score: 9.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 9.4

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

2.3

REFERENCES

CVE-2026-86206

SUMMARY

A vulnerability in the N-central internal API access control filter allows unauthorised access to internal APIs. This is fixed in N-central 2026.3 HF3 and 2026.4

Published

Date2026-09-05

Updated

Date2026-09-05

RISK INFORMATION (Score: )

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-86060

SUMMARY

RouterOS contains an argument-handling flaw in the SSH login path involving usernames that begin with a prohibited character, allowing for the trusted RouterOS policy mask to be changed, leading to privilege escalation. Exploitation requires an unauthenticated SSH session to reach the RouterOS login helper.This issue was fixed in versions: 6.49.21 (Long-term), 7.23.4 (Long-term) and 7.24.2 (Stable)

Published

Date2026-09-05

Updated

Date2026-09-05

RISK INFORMATION (Score: )

cvss4

Base Score: 9.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…